LSERS
REGN icon

Louisiana State Employees Retirement System’s Regeneron Pharmaceuticals REGN Stock Holding History

Louisiana State Employees Retirement System’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3M Sell
11,700
-200
-2% -$136K 0.11% 129
2026
Q1 		$9.19M Sell
11,900
-100
-0.8% -$76.6K 0.16% 80
2025
Q4 		$9.26M Sell
12,000
-900
-7% -$611K 0.16% 79
2025
Q3 		$7.25M Sell
12,900
-400
-3% -$226K 0.12% 112
2025
Q2 		$6.98M Sell
13,300
-300
-2% -$167K 0.13% 113
2025
Q1 		$8.63M Hold
13,600
– – 0.17% 80
2024
Q4 		$9.69M Sell
13,600
-700
-5% -$587K 0.18% 72
2024
Q3 		$15M Sell
14,300
-300
-2% -$334K 0.28% 48
2024
Q2 		$15.3M Hold
14,600
– – 0.3% 47
2024
Q1 		$14.1M Sell
14,600
-400
-3% -$380K 0.27% 51
2023
Q4 		$13.2M Hold
15,000
– – 0.27% 56
2023
Q3 		$12.3M Buy
15,000
+1,600
+12% +$1.26M 0.28% 50
2023
Q2 		$9.63M Buy
13,400
+1,000
+8% +$771K 0.21% 67
2023
Q1 		$10.2M Buy
12,400
+200
+2% +$151K 0.26% 62
2022
Q4 		$8.8M Sell
12,200
-500
-4% -$369K 0.24% 69
2022
Q3 		$8.75M Buy
12,700
+100
+0.8% +$62.9K 0.26% 61
2022
Q2 		$7.51M Buy
12,600
+200
+2% +$130K 0.2% 82
2022
Q1 		$8.92M Buy
12,400
+200
+2% +$127K 0.21% 74
2021
Q4 		$7.71M Buy
12,200
+300
+3% +$184K 0.17% 88
2021
Q3 		$7.2M Hold
11,900
– – 0.17% 89
2021
Q2 		$6.65M Hold
11,900
– – 0.16% 98
2021
Q1 		$5.63M Buy
11,900
+800
+7% +$389K 0.15% 103
2020
Q4 		$5.36M Buy
11,100
+5,800
+109% +$3.13M 0.16% 99
2020
Q3 		$2.97M Buy
5,300
+1,000
+23% +$606K 0.14% 114
2020
Q2 		$2.68M Buy
4,300
+900
+26% +$511K 0.16% 101
2020
Q1 		$1.66M Sell
3,400
-400
-11% -$165K 0.12% 162
2019
Q4 		$1.43M Hold
3,800
– – 0.07% 298
2019
Q3 		$1.05M Sell
3,800
-100
-3% -$29.6K 0.06% 446
2019
Q2 		$1.14M Sell
3,900
-200
-5% -$66.6K 0.06% 415
2019
Q1 		$1.68M Hold
4,100
– – 0.08% 244
2018
Q4 		$1.53M Sell
4,100
-400
-9% -$146K 0.09% 232
2018
Q3 		$1.82M Sell
4,500
-100
-2% -$38.1K 0.08% 254
2018
Q2 		$1.59M Sell
4,600
-100
-2% -$31.3K 0.07% 288
2018
Q1 		$1.62M Hold
4,700
– – 0.07% 281
2017
Q4 		$1.77M Sell
4,700
-100
-2% -$40.5K 0.08% 246
2017
Q3 		$2.15M Buy
4,800
+100
+2% +$47.6K 0.1% 178
2017
Q2 		$2.31M Hold
4,700
– – 0.11% 150
2017
Q1 		$1.82M Sell
4,700
-100
-2% -$37.1K 0.09% 206
2016
Q4 		$1.76M Hold
4,800
– – 0.09% 210
2016
Q3 		$1.93M Sell
4,800
-300
-6% -$120K 0.1% 176
2016
Q2 		$1.78M Sell
5,100
-100
-2% -$38.5K 0.09% 199
2016
Q1 		$1.87M Sell
5,200
-200
-4% -$82.4K 0.1% 195
2015
Q4 		$2.93M Sell
5,400
-200
-4% -$108K 0.15% 107
2015
Q3 		$2.6M Buy
5,600
+100
+2% +$53.7K 0.13% 123
2015
Q2 		$2.81M Buy
5,500
+200
+4% +$97.6K 0.13% 124
2015
Q1 		$2.39M Sell
5,300
-300
-5% -$127K 0.11% 149
2014
Q4 		$2.3M Sell
5,600
-100
-2% -$39.3K 0.11% 167
2014
Q3 		$2.06M Sell
5,700
-600
-10% -$201K 0.1% 181
2014
Q2 		$1.78M Buy
6,300
+100
+2% +$29.6K 0.08% 241
2014
Q1 		$1.86M Sell
6,200
-100
-2% -$30.8K 0.09% 216
2013
Q4 		$1.73M Buy
+6,300
New +$1.81M 0.08% 238

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Louisiana State Employees Retirement System's REGN Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q2 2026, selling an estimated $136K and leaving 11,700 shares worth $7.3M. The position accounts for 0.11% of the portfolio, ranked #129.

Louisiana State Employees Retirement System first reported a position in REGN in Q4 2013 and has held it in 51 quarters since. The position peaked at $15.3M in Q2 2024. 374 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Louisiana State Employees Retirement System held 11,700 shares of Regeneron Pharmaceuticals worth $7.3M as of Q2 2026.
  • Louisiana State Employees Retirement System sold 200 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $136K.
  • Regeneron Pharmaceuticals made up 0.11% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #129 holding.
  • Louisiana State Employees Retirement System first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • Louisiana State Employees Retirement System's Regeneron Pharmaceuticals position peaked at $15.3M in Q2 2024.
  • 374 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.